Succination of Keap1 and Activation of Nrf2-Dependent Antioxidant Pathways in FH-Deficient Papillary Renal Cell Carcinoma Type 2
- 1 October 2011
- journal article
- editorial
- Published by Elsevier BV in Cancer Cell
- Vol. 20 (4), 418-420
- https://doi.org/10.1016/j.ccr.2011.10.005
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell CarcinomaCancer Cell, 2011
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 SignalingCancer Cell, 2011
- Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydrataseNature, 2011
- Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation statusThe Journal of Pathology, 2011
- Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCCNature Reviews Urology, 2011
- Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolutionGenes to Cells, 2011
- Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 PathwayAntioxidants and Redox Signaling, 2010
- Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domainsProceedings of the National Academy of Sciences, 2010
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin LigasesMolecular Cell, 2009
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002